Recherche
-
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
(British Journal of Haematology. vol. 188, n° 6, pp. 935–944, 2020)Article de revue -
MiR-10a and HOXB4 are overexpressed in atypical myeloproliferative neoplasms
(BMC Cancer. vol. 18, n° 1, pp. 1098, 2018-12)Article de revue -
Quantification of the Mutant CALR Allelic Burden by Digital PCR
(The Journal of Molecular Diagnostics. vol. 18, n° 1, pp. 68–74, 2016-01)Article de revue -
Long-term follow-up of JAK2 exon 12 polycythemia vera: a French Intergroup of Myeloproliferative Neoplasms (FIM) study.
(Leukemia, 2020-07-21)Article de revue -
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
(Blood Advances. vol. 5, n° 5, pp. 1442-1451, 2021-03-09)Article de revue -
JAK2V617F and CALR double mutations are more frequently encountered in patients with low JAK2V617F allelic burdens
(Leukemia & lymphoma. vol. 57, n° 8, pp. 1949–1951, 2016-08)Article de revue